SUARDI, NAZARENO
 Distribuzione geografica
Continente #
NA - Nord America 7.764
AS - Asia 6.270
SA - Sud America 2.340
EU - Europa 1.806
Continente sconosciuto - Info sul continente non disponibili 320
AF - Africa 164
OC - Oceania 11
AN - Antartide 1
Totale 18.676
Nazione #
US - Stati Uniti d'America 7.473
SG - Singapore 2.499
BR - Brasile 1.967
CN - Cina 1.061
HK - Hong Kong 1.016
VN - Vietnam 609
TR - Turchia 307
RU - Federazione Russa 306
FR - Francia 300
GB - Regno Unito 283
BD - Bangladesh 269
IT - Italia 264
IE - Irlanda 241
AR - Argentina 167
CA - Canada 145
IN - India 132
DE - Germania 114
IQ - Iraq 75
MX - Messico 64
EC - Ecuador 61
ID - Indonesia 61
SE - Svezia 52
ZA - Sudafrica 52
FI - Finlandia 48
UA - Ucraina 41
CO - Colombia 38
SA - Arabia Saudita 33
PK - Pakistan 31
ES - Italia 29
PY - Paraguay 26
CL - Cile 24
MA - Marocco 20
NL - Olanda 20
PL - Polonia 20
TN - Tunisia 19
JM - Giamaica 18
KE - Kenya 18
VE - Venezuela 18
AT - Austria 17
JP - Giappone 17
JO - Giordania 16
UY - Uruguay 16
UZ - Uzbekistan 16
EG - Egitto 15
AE - Emirati Arabi Uniti 14
PE - Perù 14
PH - Filippine 14
NP - Nepal 13
HN - Honduras 12
AU - Australia 11
AZ - Azerbaigian 11
KZ - Kazakistan 11
CZ - Repubblica Ceca 10
DZ - Algeria 10
BH - Bahrain 9
TT - Trinidad e Tobago 9
LB - Libano 8
PT - Portogallo 8
CH - Svizzera 7
CR - Costa Rica 7
OM - Oman 7
SN - Senegal 7
AL - Albania 6
BO - Bolivia 6
ET - Etiopia 6
IL - Israele 6
BE - Belgio 5
DO - Repubblica Dominicana 5
NI - Nicaragua 5
RS - Serbia 5
SV - El Salvador 5
AM - Armenia 4
BB - Barbados 4
GR - Grecia 4
LT - Lituania 4
LV - Lettonia 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
AO - Angola 3
BG - Bulgaria 3
CI - Costa d'Avorio 3
GE - Georgia 3
GT - Guatemala 3
HU - Ungheria 3
KW - Kuwait 3
NG - Nigeria 3
PR - Porto Rico 3
XK - ???statistics.table.value.countryCode.XK??? 3
BM - Bermuda 2
BW - Botswana 2
CG - Congo 2
GD - Grenada 2
KG - Kirghizistan 2
MK - Macedonia 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
TW - Taiwan 2
Totale 18.331
Città #
Singapore 1.229
Hong Kong 1.016
Ashburn 839
The Dalles 497
Princeton 485
San Jose 483
New York 451
Los Angeles 306
Dallas 288
Istanbul 280
Lauterbourg 269
Dublin 244
Ho Chi Minh City 212
Beijing 178
Fairfield 150
Moscow 138
Redondo Beach 135
Hanoi 133
São Paulo 130
Des Moines 129
San Diego 126
Wilmington 123
London 122
Orem 121
Buffalo 111
Santa Clara 102
Seattle 102
Houston 101
San Francisco 98
Chicago 92
Columbus 68
Council Bluffs 66
Denver 65
Atlanta 60
Brooklyn 58
Rio de Janeiro 58
Woodbridge 56
Montreal 37
Phoenix 37
Belo Horizonte 36
Brasília 36
Cambridge 35
Milan 35
Porto Alegre 33
Helsinki 30
Toronto 30
Shanghai 29
Chennai 28
Curitiba 28
Munich 28
Romola 28
Chandler 27
Guayaquil 27
Salvador 27
Manchester 26
Rome 25
Campinas 24
Johannesburg 23
Biên Hòa 22
Erbil 22
Boston 20
Guarulhos 20
Nuremberg 20
Warsaw 20
Buenos Aires 19
Haiphong 19
Miami 19
Tianjin 19
Baghdad 18
Da Nang 18
Fortaleza 18
Goiânia 17
Hải Dương 17
Thái Bình 17
Manaus 16
Quito 16
West Jordan 16
Nairobi 15
Philadelphia 15
Recife 15
Riyadh 15
Salt Lake City 15
Amman 14
Bắc Giang 14
Campo Grande 14
Dhaka 14
Jacksonville 14
Queens 14
Ankara 13
Charlotte 13
Jakarta 13
Lahore 13
Montevideo 13
Naples 13
Norwalk 13
Raleigh 13
São José do Rio Preto 13
Tokyo 13
Turku 13
Bogotá 12
Totale 10.417
Nome #
Perioperative and Oncologic Outcomes of Nephrectomy and Caval Thrombectomy Using Extracorporeal Circulation and Deep Hypothermic Circulatory Arrest for Renal Cell Carcinoma Invading the Supradiaphragmatic Inferior Vena Cava and/or Right Atrium 2.306
Salvage therapy of small volume prostate cancer nodal failures: A review of the literature 177
Assessing Functional Outcomes of Partial Versus Radical Nephrectomy for T1b-T2 Renal Masses: Results from a Multi-institutional Collaboration 139
The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study 113
Evaluating Lichen Sclerosus in Phimosis: Insights From a Multidisciplinary Retrospective Study 107
Pathological Complete Response to Pembrolizumab plus Axitinib Combination following Serious Immune-Related Adverse Events in an Advanced Renal Cell Carcinoma Patient with a History of Rheumatoid Arthritis 107
The association of type and number of high-risk criteria with cancer-specific mortality in prostate cancer patients treated with radical prostatectomy 105
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 102
A proposal of a new nomogram for predicting upstaging in contemporary D’Amico low-risk prostate cancer patients 100
Salvage lymph node dissection: if yes, robotics? 97
A proposal of a new nomogram for predicting upstaging in contemporary D'Amico low-risk prostate cancer patients 89
A Multi-institutional Analysis of Perioperative Outcomes in 106 Men Who Underwent Radical Prostatectomy for Distant Metastatic Prostate Cancer at Presentation 89
A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer 87
Whole-body Diffusion-weighted Magnetic Resonance Imaging for Assessment of the Bone Response Rate in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Enzalutamide 85
A nomogram predicting long-term biochemical recurrence after radical prostatectomy 83
Assessment of HER2 protein overexpression and gene amplification in renal collecting duct carcinoma: Therapeutic implication 83
Management of osteomyelitis of the pubic symphysis following urinary fistula in patients with radiation-induced urethral strictures after prostate cancer treatment 82
Addition of zoledronic acid to enzalutamide and androgen deprivation therapy in metastatic hormone-sensitive prostate cancer: the randomized phase II BONENZA trial 82
PET/CT and Conventional Imaging for the Assessment of Neuroendocrine Prostate Cancer: A Systematic Review 80
Total and Regional Changes in Body Composition in Metastatic Hormone-sensitive Prostate Cancer Patients Randomized to Receive Androgen Deprivation + Enzalutamide ± Zoledronic Acid. The BONENZA Study 80
A Novel Liquid Biopsy Method Based on Specific Combinations of Vesicular Markers Allows Us to Discriminate Prostate Cancer from Hyperplasia 79
Surgical Experience and Functional Outcomes after Laparoscopic and Robot-Assisted Partial Nephrectomy: Results from a Multi-Institutional Collaboration 76
Acceptance of and discontinuation rate from erectile dysfunction oral treatment in patients following bilateral nerve-sparing radical prostatectomy 76
A Nomogram Predicting Prostate Cancer-Specific Mortality after Radical Prostatectomy 75
Are Urologists Ready for Interpretation of Multiparametric MRI Findings? A Prospective Multicentric Evaluation 74
Minimally invasive strategies for the treatment of prostate cancer recurrence after radiation therapy: a systematic review 73
A nomogram predicting metastatic progression after radical prostatectomy 73
A Preoperative Prognostic Model for Patients Treated with Nephrectomy for Renal Cell Carcinoma 73
Overall Survival of Metastatic Prostate Cancer Patients According to Location of Visceral Metastatic Sites 73
A robotic needle driver to facilitate vescico-urethral anastomosis during laparoscopic radical prostatectomy 72
Accuracy of life tables in predicting overall survival in patients after radical prostatectomy 72
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography 70
Metastasis Within Three Years from Radical Nephroureterectomy as a Potential Surrogate for Overall Survival 69
A nomogram predicting the cancer-specific mortality in patients eligible for radical cystectomy evaluating clinical data and neoadjuvant cisplatinum-based chemotherapy 69
ABLATE: a score to predict complications and recurrence rate in percutaneous treatments of renal lesions 68
What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? Results from a multi-institutional series 68
A Detailed Analysis of the Association Between Postoperative Phosphodiesterase Type 5 Inhibitor Use and the Risk of Biochemical Recurrence After Radical Prostatectomy 68
Intensive simulation training on urological mini-invasive procedures using Thiel-embalmed cadavers: The IAMSurgery experience 66
Bladder cancer histological variants: which parameters could predict the concordance between transurethral resection of bladder tumor and radical cystectomy specimens? 66
Port-site metastasis and atypical recurrences after robotic-assisted radical cystectomy (RARC): an updated comprehensive and systematic review of current evidences 66
A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer 66
Adjuvant chemotherapy for bladder cancer does not alter cancer-specific survival after cystectomy in a matched case-control study 66
A critical analysis of laser prostatectomy in the management of benign prostatic hyperplasia 65
THE RATE OF SECONDARY MALIGNANCIES AFTER RADICAL PROSTATECTOMY VERSUS EXTERNAL BEAM RADIATION THERAPY FOR LOCALIZED PROSTATE CANCER: A POPULATION-BASED STUDY ON 17,845 PATIENTS 65
Predicting Survival of Patients with Node-positive Prostate Cancer Following Multimodal Treatment 65
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 64
Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity 64
Micropapillary bladder cancer: an evolving biology 64
Long-Term Follow-up of Patients with Prostate Cancer and Nodal Metastases Treated by Pelvic Lymphadenectomy and Radical Prostatectomy: The Positive Impact of Adjuvant Radiotherapy 64
Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer 64
Immuno-oncology therapy in metastatic bladder cancer: A systematic review and network meta-analysis 63
Choosing the Best Candidates for Penile Rehabilitation after Bilateral Nerve-Sparing Radical Prostatectomy 63
Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer 62
External Validation of the European Association of Urology Recommendations for Pelvic Lymph Node Dissection in Patients Treated with Robot-Assisted Radical Prostatectomy 62
Contemporary Pathological Stage Distribution After Radical Prostatectomy in North American High-Risk Prostate Cancer Patients 62
External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients 61
Comparison of nomograms with other methods for predicting outcomes in prostate cancer: A critical analysis of the literature 61
Impact of Lymph Node Dissection on Cancer Specific Survival in Patients With Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy 61
The Role of Prostate-specific Antigen Persistence after Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients 61
When to perform preoperative chest computed tomography for renal cancer staging 61
Underestimation of positron emission tomography/computerized tomography in assessing tumor burden in prostate cancer nodal recurrence: Head-to-head comparison of 68Ga-PSMA and 11C-choline in a large, multi-institutional series of extended salvage lymph node dissections 61
Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients 61
Benign Prostatic Hyperplasia and Its Aetiologies 60
The Number of Cores at First Biopsy May Suggest the Need for a Confirmatory Biopsy in Patients Eligible for Active Surveillance-Implication for Clinical Decision Making in the Real-life Setting 60
Combination of Adjuvant Hormonal and Radiation Therapy Significantly Prolongs Survival of Patients With pT2-4 pN+ Prostate Cancer: Results of a Matched Analysis 60
Neoadjuvant Short-term Intensive Intravesical Mitomycin C Regimen Compared with Weekly Schedule for Low-grade Recurrent Non-muscle-invasive Bladder Cancer: Preliminary Results of a Randomised Phase 2 Study 60
The prognostic role of staging [18F]PSMA-1007 PET/CT volumetric and dissemination features in prostate cancer 59
Intravesical Therapy for Non-Muscle-Invasive Bladder Cancer: What Is the Real Impact of Squamous Cell Carcinoma Variant on Oncological Outcomes? 59
The Number of Cores at First Biopsy May Suggest the Need for a Confirmatory Biopsy in Patients Eligible for Active Surveillance-Implication for Clinical Decision Making in the Real-life Setting REPLY 59
Preoperative Hypogonadism Is Not an Independent Predictor of High-Risk Disease in Patients Undergoing Radical Prostatectomy 59
Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: A population-based study of 6183 men 59
Genitourinary manifestations of Lynch syndrome in the urological practice 58
Age-adjusted validation of the most stringent criteria for active surveillance in low-risk prostate cancer patients 58
Current Standard Technique for Modern Flexible Ureteroscopy: Tips and Tricks 58
A novel tool to assess the risk of urinary incontinence after nerve-sparing radical prostatectomy 58
Prostate Saturation Biopsy following a First Negative Biopsy: State of the Art 58
The impact of visceral adipose tissue on postoperative renal function after radical nephrectomy for renal cell carcinoma 58
The Surgical Learning Curve for Biochemical Recurrence After Robot-assisted Radical Prostatectomy 57
Adenocarcinoma of the Bladder: Assessment of Survival Advantage Associated With Radical Cystectomy and Comparison With Urothelial Bladder Cancer 57
More Extensive Pelvic Lymph Node Dissection Improves Survival in Patients with Node-positive Prostate Cancer 57
Selecting the Optimal Candidate for Adjuvant Radiotherapy After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis 57
Technologies for image-guided surgery for managing lymphatic metastases in prostate cancer 57
Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection in Patients with Locally-advanced Prostate Cancer 57
Re: Novel Classification for Upper Tract Urothelial Carcinoma to Better Risk-stratify Patients Eligible for Kidney-sparing Strategies: An International Collaborative Study 57
Response to Re: External beam radiotherapy and radical prostatectomy are associated with better survival in Asian prostate cancer patients 56
Robot-assisted Salvage Lymph Node Dissection for Clinically Recurrent Prostate Cancer 56
Holmium laser enucleation versus open prostatectomy for benign prostatic hyperplasia: An inpatient cost analysis 56
Age at diagnosis is a determinant factor of renal cell carcinoma-specific survival in patients treated with nephrectomy 56
Body mass index and its association with genitourinary disorders in men undergoing prostate cancer screening 56
‘En Bloc’ HoLEP with early apical release in men with benign prostatic hyperplasia 56
Increasing Rate of Noninterventional Treatment Management in Localized Prostate Cancer Candidates for Active Surveillance: A North American Population-Based Study 56
The Role of PSMA PET Imaging in the Classification of the Risk of Prostate Cancer Patients: A Systematic Review on the Insights to Guide an Active Surveillance Approach 55
Survival of patients with clear cell renal carcinoma according to number and location of organ-specific metastatic sites 55
Extended pelvic lymph node dissection in prostate cancer: a 20-year audit in a single center 55
Identifying the Optimal Candidate for Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer: Results from a Large, Multi-institutional Analysis 55
General versus spinal anesthesia in patients undergoing radical retropubic prostatectomy: Results of a prospective, randomized study 55
Improving the preservation of the urethral sphincter and neurovascular bundles during open radical retropubic prostatectomy 55
Currently Used Criteria for Active Surveillance in Men With Low-risk Prostate Cancer An Analysis of Pathologic Features 55
Population-based Analysis of Normal Total PSA and Percentage of Free/Total PSA Values: Results From Screening Cohort 55
Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men 54
Totale 9.173
Categoria #
all - tutte 151.324
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 151.324


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.304 0 3 0 0 0 560 38 70 60 195 131 247
2022/2023668 242 1 0 3 13 258 0 11 99 5 22 14
2023/20241.371 16 9 23 25 19 244 75 6 593 22 12 327
2024/20253.684 9 4 43 392 654 316 178 42 429 449 774 394
2025/202610.931 641 1.322 916 1.770 567 302 1.085 283 441 805 2.374 425
2026/2027612 390 222 0 0 0 0 0 0 0 0 0 0
Totale 18.676